5 reports of this reaction
4.1% of all AVOBENZONE, HOMOSALATE, OCTOCRYLENE reports
#2 most reported adverse reaction
MALAISE is the #2 most commonly reported adverse reaction for AVOBENZONE, HOMOSALATE, OCTOCRYLENE, manufactured by CVS. There are 5 FDA adverse event reports linking AVOBENZONE, HOMOSALATE, OCTOCRYLENE to MALAISE. This represents approximately 4.1% of all 123 adverse event reports for this drug.
Patients taking AVOBENZONE, HOMOSALATE, OCTOCRYLENE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MALAISE is moderately reported among AVOBENZONE, HOMOSALATE, OCTOCRYLENE users, representing a notable but not dominant share of adverse events.
In addition to malaise, the following adverse reactions have been reported for AVOBENZONE, HOMOSALATE, OCTOCRYLENE:
The following drugs have also been linked to malaise in FDA adverse event reports:
MALAISE has been reported as an adverse event in 5 FDA reports for AVOBENZONE, HOMOSALATE, OCTOCRYLENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MALAISE accounts for approximately 4.1% of all adverse event reports for AVOBENZONE, HOMOSALATE, OCTOCRYLENE, making it one of the most commonly reported side effect.
If you experience malaise while taking AVOBENZONE, HOMOSALATE, OCTOCRYLENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.